Pet Cancer Therapeutics Market - Global Industry Analysis

The global Pet Cancer Therapeutics market, which accrued proceeds worth 200.36 (USD Million) in 2019, is set to record the CAGR of nearly 10.7% over the period from 2020 to 2026. The report offers assessment and analysis of the Pet Cancer Therapeutics market on a global and regional level. The study offers a comprehensive assessment of the market competition, constraints, sales estimates, opportunities, evolving trends, and industry-validated data. The report offers historical data from 2017 to 2019 along with a forecast from 2020 to 2026 based on revenue (USD Million).

Introduction

Pet cancer therapeutics are new anti-cancer medicine having capacity for reducing the negative impact of cancer tissues. In addition to this, pet cancer therapeutics encompass combination therapy as well as monotherapy. Apparently, the current research activities mainly focusses on proliferation of new anti-cancer medicines for enhancing efficiency and minimizing treatment side-effects.

Market Growth Dynamics

Growing trend of adopting pets like cats & dogs across the globe will promote the expansion of pet cancer therapeutics industry over the forecast timeline. Increase in the occurrence of pet cancer in the developed nations will proliferate the pet cancer therapeutics market progression in the years to come. Additionally, a surge in the pet populace in the countries like the U.S., UK, and Germany will culminate in humungous market demand over the estimated timespan.

Furthermore, rise in the awareness about the pet ailments along with rise in tendency towards spending on pet care as well as treatment of pets will exponentiate the growth of the pet cancer therapeutics industry over the forecasting years. Additionally, rise in various kinds of cancers in dogs & cats and surge in the funding of research activities pertaining to cancer therapy in canines & cats will prompt the business growth over the span of next few years.    

North America To Account For Major Market Share Over 2020-2026

The growth of the market in the North American sub-continent over the forecast timeline is due to huge presence of reputed industry participants in the countries like the U.S. and the UK. Additionally, a large-scale product penetration as well as product innovation to effectively treat various kinds of pet cancers will elevate the market growth over the estimated timeline.

Key players influencing the market growth include Karyopharm Therapeutics, Inc., Zoetis, Oasmia Pharmaceuticals AB, Zenoaq, AB Science, Aratana Therapeutics, Inc., Rhizen Pharmaceuticals SA, Morphogenesis, Inc., Boehringer Ingelheim International GmbH, Regeneus Ltd., and VetDC, Inc.

The global pet cancer therapeutics market is segmented as follows:

By Route of Administration

• Parenteral
• Oral
• Others

By Cancer type

• Melanoma
• Lymphoma
• Mammary & squamous cell cancer
• Mast cell cancer
• Others

By species type

• Cat
• Dog
• Others

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa

About Us:

Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Contact Us:

Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com

• Chapter 1. Preface
  • 1.1. Report Description and Scope
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology
• Chapter 2. Executive Summary
  • 2.1. Pet Cancer Therapeutics Market, 2016–2026(USD Million)
  • 2.2. Pet Cancer Therapeutics Market: Snapshot
• Chapter 3. Global Pet Cancer Therapeutics Market– Industry Analysis
  • 3.1. Pet Cancer Therapeutics Market: Market Dynamics
  • 3.2. Market Drivers
    • 3.2.1. Growing trend of adopting pets like cats & dogs across the globe will promote the expansion of pet cancer therapeutics industry over the forecast timeline.
    • 3.2.2. Increase in the occurrence of pet cancer in the developed nations will pruliferate the pet cancer therapeutics market progression in the years to come.
  • 3.3. Market Attractiveness Analysis
    • 3.3.1. Market attractiveness analysis By Route Of Administration
    • 3.3.2. Market attractiveness analysis By Cancer Type
    • 3.3.3. Market attractiveness analysis By Species Type
• Chapter 4. Global Pet Cancer Therapeutics Market– Competitive Landscape
  • 4.1. Company market share analysis
    • 4.1.1. Global Pet Cancer Therapeutics Market: company market share, 2019
  • 4.2. Strategic development
    • 4.2.1. Acquisitions & mergers
    • 4.2.2. New Product Type launches
    • 4.2.3. Agreements, partnerships, cullaborations, and joint ventures
    • 4.2.4. Research and development and Regional expansion
  • 4.3. Price trend analysis
• Chapter 5. Global Pet Cancer Therapeutics Market– By Route Of Administration Analysis
  • 5.1. Global Pet Cancer Therapeutics Market overview: By Route Of Administration
    • 5.1.1. Global Pet Cancer Therapeutics Market share, By Route Of Administration ,2019 and 2026
  • 5.2. Parenteral
    • 5.2.1. Global Pet Cancer Therapeutics Market by Parenteral, 2016–2026(USD Million)
  • 5.3. Oral
    • 5.3.1. Global Pet Cancer Therapeutics Market by Oral, 2016–2026(USD Million)
  • 5.4. Others
    • 5.4.1. Global Pet Cancer Therapeutics Market by Others, 2016–2026(USD Million)
• Chapter 6. Global Milk Packaging Market– Cancer Type Analysis
  • 6.1. Global Pet Cancer Therapeutics Market overview: By Cancer Type
    • 6.1.1. Global Pet Cancer Therapeutics Market share, By Cancer Type , 2019 and 2026
  • 6.2. Melanoma
    • 6.2.1. Global Pet Cancer Therapeutics Market By Melanoma, 2016–2026(USD Million)
  • 6.3. Mast Cell Cancer
    • 6.3.1. Global Pet Cancer Therapeutics Market By Mast Cell Cancer, 2016–2026(USD Million)
  • 6.4. Lymphoma
    • 6.4.1. Global Pet Cancer Therapeutics Market By Lymphoma, 2016–2026(USD Million)
  • 6.5. Mammary & Squamous Cell Cancer
    • 6.5.1. Global Pet Cancer Therapeutics Market By Mammary & Squamous Cell Cancer, 2016–2026(USD Million)
  • 6.6. Others
    • 6.6.1. Global Pet Cancer Therapeutics Market By Others, 2016–2026(USD Million)
• Chapter 7. Global Milk Packaging Market– Species Type Analysis
  • 7.1. Global Pet Cancer Therapeutics Market overview: By Species Type
    • 7.1.1. Global Pet Cancer Therapeutics Market share, By Species Type, 2019 and 2026
  • 7.2. Cat
    • 7.2.1. Global Pet Cancer Therapeutics Market By Cat, 2016–2026(USD Million)
  • 7.3. Dog
    • 7.3.1. Global Pet Cancer Therapeutics Market By Dog, 2016–2026(USD Million)
  • 7.4. Others
    • 7.4.1. Global Pet Cancer Therapeutics Market By Others, 2016–2026(USD Million)
• Chapter 8. Company Profiles
  • 8.1. Aratana Therapeutics, Inc.
    • 8.1.1. Overview
    • 8.1.2. Financials
    • 8.1.3. Product Portfolio
    • 8.1.4. Business Strategy
    • 8.1.5. Recent Developments
  • 8.2. Oasmia Pharmaceuticals AB
    • 8.2.1. Overview
    • 8.2.2. Financials
    • 8.2.3. Product Portfolio
    • 8.2.4. Business Strategy
    • 8.2.5. Recent Developments
  • 8.3. Zenoaq
    • 8.3.1. Overview
    • 8.3.2. Financials
    • 8.3.3. Product Portfolio
    • 8.3.4. Business Strategy
    • 8.3.5. Recent Developments
  • 8.4. AB Science
    • 8.4.1. Overview
    • 8.4.2. Financials
    • 8.4.3. Product Portfolio
    • 8.4.4. Business Strategy
    • 8.4.5. Recent Developments
  • 8.5. Rhizen Pharmaceuticals SA
    • 8.5.1. Overview
    • 8.5.2. Financials
    • 8.5.3. Product Portfolio
    • 8.5.4. Business Strategy
    • 8.5.5. Recent Development
  • 8.6. Rhizen Pharmaceuticals SA
    • 8.6.1. Overview
    • 8.6.2. Financials
    • 8.6.3. Product Portfolio
    • 8.6.4. Business Strategy
    • 8.6.5. Recent Development
  • 8.7. Morphogenesis, Inc.
    • 8.7.1. Overview
    • 8.7.2. Financials
    • 8.7.3. Product Portfolio
    • 8.7.4. Business Strategy
    • 8.7.5. Recent Development
  • 8.8. Karyopharm Therapeutics, Inc.
    • 8.8.1. Overview
    • 8.8.2. Financials
    • 8.8.3. Product Portfolio
    • 8.8.4. Business Strategy
    • 8.8.5. Recent Development
  • 8.9. Boehringer Ingelheim International GmbH
    • 8.9.1. Overview
    • 8.9.2. Financials
    • 8.9.3. Product Portfolio
    • 8.9.4. Business Strategy
    • 8.9.5. Recent Development
  • 8.10. Regeneus Ltd.
    • 8.10.1. Overview
    • 8.10.2. Financials
    • 8.10.3. Product Portfolio
    • 8.10.4. Business Strategy
    • 8.10.5. Recent Development
  • 8.11. Zoetis
    • 8.11.1. Overview
    • 8.11.2. Financials
    • 8.11.3. Product Portfolio
    • 8.11.4. Business Strategy
    • 8.11.5. Recent Development
  • 8.12. VetDC, Inc.
    • 8.12.1. Overview
    • 8.12.2. Financials
    • 8.12.3. Product Portfolio
    • 8.12.4. Business Strategy
    • 8.12.5. Recent Development

Table Of Figures

List of Figures

1. Market research process
2. Market research methodology
3. Global Pet Cancer Therapeutics Market, 2016–2026(USD Million)
4. Porter’s Five Forces Analysis
5. Global Pet Cancer Therapeutics Market attractiveness, By Route Of Administration  
6. Global Pet Cancer Therapeutics Market attractiveness, By Cancer Type  
7. Global Pet Cancer Therapeutics Market share, By Route Of Administration  , 2019 and 2026 (USD Million)
8. Global Pet Cancer Therapeutics Market by  Parenteral,2016–2026(USD Million)
9. Global Pet Cancer Therapeutics Market by  Oral,2016–2026(USD Million)
10. Global Pet Cancer Therapeutics Market by  Others,2016–2026(USD Million)
11. Global Pet Cancer Therapeutics Market share by Cancer Type  ,2019 and 2026 (USD Million)
12. Global Pet Cancer Therapeutics Market by  Melanoma, 2016–2026(USD Million)
13. Global Pet Cancer Therapeutics Market by  Lymphoma, 2016–2026(USD Million)
14. Global Pet Cancer Therapeutics Market by  Mast Cell Cancer, 2016–2026(USD Million)
15. Global Pet Cancer Therapeutics Market by  Mammary & Squamous Cell Cancer, 2016–2026(USD Million)
16. Global Pet Cancer Therapeutics Market by  Others, 2016–2026(USD Million)
17. Global Pet Cancer Therapeutics Market share by Species Type  ,2019 and 2026 (USD Million)
18. Global Pet Cancer Therapeutics Market by  Cat, 2016–2026(USD Million)
19. Global Pet Cancer Therapeutics Market by  Dog, 2016–2026(USD Million)
20. Global Pet Cancer Therapeutics Market by  Others, 2016–2026(USD Million)
21. Global Pet Cancer Therapeutics Market share, by Region, 2019 and 2026
22. North America Pet Cancer Therapeutics Market, 2016–2026(USD Million)
23. Europe Pet Cancer Therapeutics Market, 2016–2026(USD Million)
24. Asia Pacific Pet Cancer Therapeutics Market, 2016–2026(USD Million)
25. Latin America Pet Cancer Therapeutics Market, 2016–2026(USD Million)
26. The Middle East and Africa Pet Cancer Therapeutics Market, 2016–2026(USD Million)

Table Of Tables

List of Tables

1. Global Pet Cancer Therapeutics Market: snapshot
2. Drivers of the Pet Cancer Therapeutics Market: impact analysis
3. North America Pet Cancer Therapeutics Market revenue, By Route of Administration ,2016–2026(USD Million)
4. North America Pet Cancer Therapeutics Market revenue, By Cancer Type  , 2016–2026(USD Million)
5. North America Pet Cancer Therapeutics Market revenue, By Species Type  , 2016–2026(USD Million)
6. The U.S. Pet Cancer Therapeutics Market revenue, By Route Of Administration  , 2016–2026(USD Million)
7. The U.S. Pet Cancer Therapeutics Market revenue, By Cancer Type  , 2016–2026(USD Million)
8. The U.S. Pet Cancer Therapeutics Market revenue, By Species Type  , 2016–2026(USD Million)
9. Rest of North America Pet Cancer Therapeutics Market revenue, By Route Of Administration  ,2016–2026(USD Million)
10. Rest of North America Pet Cancer Therapeutics Market revenue, By Cancer Type  , 2016–2026(USD Million)
11. Rest of North America Pet Cancer Therapeutics Market revenue, By Species Type  , 2016–2026(USD Million)
12. Europe Pet Cancer Therapeutics Market revenue, By Route Of Administration  , 2016–2026(USD Million)
13. Europe Pet Cancer Therapeutics Market revenue, By Cancer Type  , 2016–2026(USD Million)
14. Europe Pet Cancer Therapeutics Market revenue, By Species Type  , 2016–2026(USD Million)
15. UK Pet Cancer Therapeutics Market revenue, By Route Of Administration  ,2016–2026(USD Million)
16. UK Pet Cancer Therapeutics Market revenue, By Cancer Type  , 2016–2026(USD Million)
17. UK Pet Cancer Therapeutics Market revenue, By Species Type  , 2016–2026(USD Million)
18. France Pet Cancer Therapeutics Market revenue, By Route Of Administration  ,2016–2026(USD Million)
19. France Pet Cancer Therapeutics Market revenue, By Cancer Type  , 2016–2026(USD Million)
20. France Pet Cancer Therapeutics Market revenue, By Species Type  , 2016–2026(USD Million)
21. Germany Pet Cancer Therapeutics Market revenue, By Route Of Administration  ,2016–2026(USD Million)
22. Germany Pet Cancer Therapeutics Market revenue, By Cancer Type  , 2016–2026(USD Million)
23. Germany Pet Cancer Therapeutics Market revenue, By Species Type  , 2016–2026(USD Million)
24. Rest of Europe Pet Cancer Therapeutics Market revenue, By Route Of Administration  ,2016–2026(USD Million)
25. Rest of Europe Pet Cancer Therapeutics Market revenue, By Cancer Type  , 2016–2026(USD Million)
26. Rest of Europe Pet Cancer Therapeutics Market revenue, By Species Type  , 2016–2026(USD Million)
27. Asia Pacific Pet Cancer Therapeutics Market revenue, By Route Of Administration  ,2016–2026(USD Million)
28. Asia Pacific Pet Cancer Therapeutics Market revenue, By Cancer Type , 2016–2026(USD Million)
29. Asia Pacific Pet Cancer Therapeutics Market revenue, By Species Type , 2016–2026(USD Million)
30. China Pet Cancer Therapeutics Market revenue, By Route Of Administration  ,2016–2026(USD Million)
31. China Pet Cancer Therapeutics Market revenue, By Cancer Type  , 2016–2026(USD Million)
32. China Pet Cancer Therapeutics Market revenue, By Species Type  , 2016–2026(USD Million)
33. Japan Pet Cancer Therapeutics Market revenue, By Route Of Administration  , 2016–2026(USD Million)
34. Japan Pet Cancer Therapeutics Market revenue, By Cancer Type  , 2016–2026(USD Million)
35. Japan Pet Cancer Therapeutics Market revenue, By Species Type  , 2016–2026(USD Million)
36. India Pet Cancer Therapeutics Market revenue, By Route Of Administration  ,2016–2026(USD Million)
37. India Pet Cancer Therapeutics Market revenue, By Cancer Type  , 2016–2026(USD Million)
38. India Pet Cancer Therapeutics Market revenue, By Species Type  , 2016–2026(USD Million)
39. Rest of Asia Pacific Pet Cancer Therapeutics Market revenue, By Route Of Administration  ,2016–2026(USD Million)
40. Rest of Asia Pacific Pet Cancer Therapeutics Market revenue, By Cancer Type  , 2016–2026(USD Million)
41. Rest of Asia Pacific Pet Cancer Therapeutics Market revenue, By Species Type  , 2016–2026(USD Million)
42. Latin America Pet Cancer Therapeutics Market revenue, By Route Of Administration  ,2016–2026(USD Million)
43. Latin America Pet Cancer Therapeutics Market revenue, By Cancer Type , 2016–2026(USD Million)
44. Latin America Pet Cancer Therapeutics Market revenue, By Species Type , 2016–2026(USD Million)
45. Brazil Pet Cancer Therapeutics Market revenue, By Route Of Administration  ,2016–2026(USD Million)
46. Brazil Pet Cancer Therapeutics Market revenue, By Cancer Type , 2016–2026(USD Million)
47. Brazil Pet Cancer Therapeutics Market revenue, By Species Type , 2016–2026(USD Million)
48. Rest of Latin America Pet Cancer Therapeutics Market revenue, By Route Of Administration  ,2016–2026(USD Million)
49. Rest of Latin America Pet Cancer Therapeutics Market revenue, By Cancer Type  , 2016–2026(USD Million)
50. Rest of Latin America Pet Cancer Therapeutics Market revenue, By Species Type  , 2016–2026(USD Million)
51. The Middle East and Africa Pet Cancer Therapeutics Market revenue, By Route Of Administration  ,2016–2026(USD Million)
52. The Middle East and Africa Pet Cancer Therapeutics Market revenue, By Cancer Type  , 2016–2026(USD Million)
53. The Middle East and Africa Pet Cancer Therapeutics Market revenue, By Species Type  , 2016–2026(USD Million)
54. Saudi Arabia Pet Cancer Therapeutics Market revenue, By Route Of Administration  , 2016–2026(USD Million)
55. Saudi Arabia Pet Cancer Therapeutics Market revenue, By Cancer Type  , 2016–2026(USD Million)
56. Saudi Arabia Pet Cancer Therapeutics Market revenue, By Species Type  , 2016–2026(USD Million)
57. South Africa Pet Cancer Therapeutics Market revenue, By Route Of Administration  ,2016–2026(USD Million)
58. South Africa Pet Cancer Therapeutics Market revenue, By Cancer Type  , 2016–2026(USD Million)
59. South Africa Pet Cancer Therapeutics Market revenue, By Species Type  , 2016–2026(USD Million)
60. Rest of the Middle East & Africa Pet Cancer Therapeutics Market revenue, By Route Of Administration  ,2016–2026(USD Million)
61. Rest of the Middle East & Africa Pet Cancer Therapeutics Market revenue, By Cancer Type  , 2016–2026(USD Million)
62. Rest of the Middle East & Africa Pet Cancer Therapeutics Market revenue, By Species Type  , 2016–2026(USD Million)